As a research-based global pharmaceutical company with a strong commitment to developing and marketing innovative medicines for therapeutic areas with significant unmet needs, it is imperative that Takeda has multiple opportunities to engage with U.S. policymakers and policy influencers in healthcare and related public policy debates. The U.S. government accounts for nearly half of all U.S. healthcare spending, and its policies, legislation, and regulations impact the entire healthcare system. In order to ensure that Takeda’s point of view is considered by policymakers in critical debates affecting our products and therapeutic areas, we must provide a regular stream of information over time to educate those elected officials on both sides of the aisle. Elected officials, no matter what level, have an impact on public policy issues affecting Takeda. In the U.S., we are committed to backing candidates of any party who support public policies that contribute to the health needs of our patients, pharmaceutical innovation, and the interests of our company.
Government actions such as price controls, pharmaceutical manufacturer rebates, and limiting access to Takeda’s medicines affect our ability to invest in innovation and patients’ ability to realize health benefits from those investments. Takeda, through its Government and External Affairs function, helps inform the U.S. debate over healthcare and pharmaceutical innovation at the federal, state, and local levels.
We believe that public policy engagement is an important and appropriate role for companies in open societies, when conducted in a legal and transparent manner. In the U.S. there are important federal and state lobbying registration and disclosure laws with which Takeda complies.
Takeda Pharmaceuticals and its political action committee, Takeda Pharmaceuticals America PAC, or TakPAC, are committed to transparency around the political process at the state and federal levels. Where required, Takeda reports both lobbying activity and disbursement of political funds to candidates at state and federal levels. Takeda also files quarterly lobbying reports that capture federal lobbying activity in the U.S. House and Senate and with any federal agencies. Takeda’s lobbying reports can be found at http://lobbyingdisclosure.house.gov.
TakPAC is a separate, segregated fund that is registered with the Federal Election Commission as a multi-candidate political action committee, connected with Takeda Pharmaceuticals America. The committee is Lobbyist/Registrant PAC. TakPAC is a monthly filer reporting activity twelve times a year with additional reporting requirements during election years. TakPAC reports are publicly available and can be found at www.fec.gov.
The purpose of TakPAC is to provide monetary contributions and other support to candidates for federal, state, and local offices. Employee participation in TakPAC is completely voluntary, all contribution guidelines are only suggestions, and employees are free to contribute more or less than the guidelines or nothing at all. Takeda will neither favor nor disadvantage any employee by reason of the amount of his or her contribution or decision not to contribute. Employees may refuse to contribute without reprisal.
Takeda is a member of several industry and trade groups that represent both the pharmaceutical industry and the business community at large in an effort to bring about consensus on broad policy issues that can impact Takeda’s business objectives and ability to serve patients. Takeda’s participation as a member of these various industry and trade groups comes with the understanding that we may not always agree with the positions of the larger organization and/or other members, and that we are committed to voicing our concerns as appropriate through our colleagues who serve on the boards and committees of these groups. Below is a partial listing of our current memberships.